Menu
Back to User profile » Prof. Dr. Pengming Sun
Papers published by Prof. Dr. Pengming Sun:
Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer
Ma J, Lin J, Lin X, Ren Y, Liu D, Tang S, Huang L, Xu S, Mao X, Sun P
Journal of Inflammation Research 2024, 17:2039-2050
Published Date: 2 April 2024
Peripheral Blood Lymphocyte Subsets as a Risk Predictor of Patients with Endometrioid Endometrial Cancer
Su P, An J, Yu L, Lei H, Huang L, Mao X, Sun P
Journal of Inflammation Research 2022, 15:6153-6163
Published Date: 8 November 2022
Low Level FLT3LG is a Novel Poor Prognostic Biomarker for Cervical Cancer with Immune Infiltration
chen L, Huang Y, Dong B, Gu Y, Li Y, Cang W, Sun P, Xiang Y
Journal of Inflammation Research 2022, 15:5889-5904
Published Date: 19 October 2022
Systemic Immune-Inflammatory Index as a Predictor of Lymph Node Metastasis in Endometrial Cancer
Lei H, Xu S, Mao X, Chen X, Chen Y, Sun X, Sun P
Journal of Inflammation Research 2021, 14:7131-7142
Published Date: 21 December 2021
Immunohistochemical Analysis of PGC-1α and ERRα Expression Reveals Their Clinical Significance in Human Ovarian Cancer
Huang X, Ruan G, Liu G, Gao Y, Sun P
OncoTargets and Therapy 2020, 13:13055-13062
Published Date: 22 December 2020
Risk Factors for Residual Disease in Hysterectomy Specimens After Conization in Post-Menopausal Patients with Cervical Intraepithelial Neoplasia Grade 3
Sun X, Lei H, Xie X, Ruan G, An J, Sun P
International Journal of General Medicine 2020, 13:1067-1074
Published Date: 10 November 2020
HPV-16 E2/E6 and POU5F1B as Biomarkers to Determine Cervical High-Grade Squamous Lesions and More
Chen L, Dong B, Gao H, Xue H, Pan D, Sun P
Journal of Inflammation Research 2020, 13:813-821
Published Date: 29 October 2020
Malignant Ovarian Tumors During Pregnancy: A Multicenter Retrospective Analysis
Wang L, Huang S, Sheng X, Ren C, Wang Q, Yang L, Zhao S, Xu T, Ma X, Guo R, Sun P, Lin Y, Li Y, Wang J, Wang Y
Cancer Management and Research 2020, 12:10841-10848
Published Date: 29 October 2020
Low Red Blood Cell Count as an Early Indicator for Myometrial Invasion in Women with Endometrioid Endometrial Carcinoma with Metabolic Syndrome
Tong Y, Xie X, Mao X, Lei H, Chen Y, Sun P
Cancer Management and Research 2020, 12:10849-10859
Published Date: 29 October 2020
The Role of Obstetric Factors, miRNA-30d and miRNA-181a in Postpartum Women with Pelvic Organ Prolapse
Lin W, Lin L, Dong B, Chen L, Lei H, Gao Y, Chen Y, Sun P
Risk Management and Healthcare Policy 2020, 13:2309-2316
Published Date: 28 October 2020
The Triage Effectiveness of an Extended High-Risk Human Papillomavirus Genotyping Assay for Women with Cytology Showing Atypical Squamous Cells of Undetermined Significance in China
Pan D, Dong B, Gao H, Mao X, Xue H, Sun P
Risk Management and Healthcare Policy 2020, 13:1747-1756
Published Date: 24 September 2020
Evaluation of Knowledge and Attitude Toward HPV and Vaccination Among Medical Staff, Medical Students, and Community Members in Fujian Province
Yu C, Chen L, Ruan G, An J, Sun P
Risk Management and Healthcare Policy 2020, 13:989-997
Published Date: 3 August 2020
Evaluation of PCR-Reverse Dot Blot Human Papillomavirus Genotyping Test in Predicting Residual/Recurrent CIN 2+ in Posttreatment Patients in China
Zhang Q, Dong B, Chen L, Lin T, Tong Y, Lin W, Lin H, Gao Y, Lin F, Sun P
Cancer Management and Research 2020, 12:2369-2379
Published Date: 1 April 2020
Dual targeting of estrogen receptor α and estrogen-related receptor α: a novel endocrine therapy for endometrial cancer
Mao X, Dong B, Gao M, Ruan G, Huang M, Braicu EI, Sehouli J, Sun P
OncoTargets and Therapy 2019, 12:6757-6767
Published Date: 20 August 2019
Key regulator of cellular metabolism, estrogen-related receptor α, a new therapeutic target in endocrine-related gynecological tumor
Liu G, Sun P, Dong B, Sehouli J
Cancer Management and Research 2018, 10:6887-6895
Published Date: 12 December 2018
Clinical validation of the Cervista® high-risk human papillomavirus test in Chinese women from Fujian province: a cross-sectional study
Mao X, Ruan G, Dong B, Chen L, Xu S, Lin F, Sun P
Therapeutics and Clinical Risk Management 2018, 14:2243-2253
Published Date: 16 November 2018
Type-specific high-risk human papillomavirus viral load as a viable triage indicator for high-grade squamous intraepithelial lesion: a nested case–control study
Dong B, Sun P, Ruan G, Huang W, Mao X, Kang Y, Pan D, Lin F
Cancer Management and Research 2018, 10:4839-4851
Published Date: 23 October 2018
Cervical cancer screening using the Cervista high-risk human papillomavirus test: opportunistic screening of a hospital-based population in Fujian province, China
Ruan GY, Song YY, Dong BH, Mao XD, Lin F, Kang YF, Xu SX, Chen XJ, Wu QB, Sun PM
Cancer Management and Research 2018, 10:3227-3235
Published Date: 4 September 2018
Novel endocrine therapeutic strategy in endometrial carcinoma targeting estrogen-related receptor α by XCT790 and siRNA
Sun PM, Mao XD, Gao M, Huang MM, Chen LL, Ruan GY, Huang WY, Braicu EI, Sehouli J
Cancer Management and Research 2018, 10:2521-2535
Published Date: 10 August 2018
The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
Ruan GY, Ye LX, Liu GF, An J, Sehouli J, Sun PM
OncoTargets and Therapy 2018, 11:521-528
Published Date: 23 January 2018